Soleno Therapeutics Stock Probability of Future Stock Price Finishing Under 41.49
Soleno Therapeutics' future price is the expected price of Soleno Therapeutics instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Soleno Therapeutics performance during a given time horizon utilizing its historical volatility. Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
Please specify Soleno Therapeutics' target price for which you would like Soleno Therapeutics odds to be computed.
Soleno |
Soleno Therapeutics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Soleno Therapeutics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Soleno Therapeutics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Soleno Therapeutics is not yet fully synchronised with the market data | |
| Soleno Therapeutics generated a negative expected return over the last 90 days | |
| Soleno Therapeutics has some characteristics of a very speculative penny stock | |
| Soleno Therapeutics has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (38.99 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Soleno Therapeutics currently holds about 24.07 M in cash with (24.94 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.97. | |
| Over 97.0% of the company shares are owned by institutional investors |
Soleno Therapeutics Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Soleno Stock often depends not only on the future outlook of the current and potential Soleno Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Soleno Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 16.5 M | |
| Cash And Short Term Investments | 169.7 M |
Soleno Therapeutics Technical Analysis
Soleno Therapeutics' future price can be derived by breaking down and analyzing its technical indicators over time. Soleno Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Soleno Therapeutics. In general, you should focus on analyzing Soleno Stock price patterns and their correlations with different microeconomic environments and drivers.
Soleno Therapeutics Predictive Forecast Models
Soleno Therapeutics' time-series forecasting models is one of many Soleno Therapeutics' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Soleno Therapeutics' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Soleno Therapeutics
Checking the ongoing alerts about Soleno Therapeutics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Soleno Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Soleno Therapeutics is not yet fully synchronised with the market data | |
| Soleno Therapeutics generated a negative expected return over the last 90 days | |
| Soleno Therapeutics has some characteristics of a very speculative penny stock | |
| Soleno Therapeutics has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (38.99 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Soleno Therapeutics currently holds about 24.07 M in cash with (24.94 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.97. | |
| Over 97.0% of the company shares are owned by institutional investors |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Soleno Therapeutics. If investors know Soleno will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Soleno Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Soleno Therapeutics is measured differently than its book value, which is the value of Soleno that is recorded on the company's balance sheet. Investors also form their own opinion of Soleno Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Soleno Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Soleno Therapeutics' market value can be influenced by many factors that don't directly affect Soleno Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Soleno Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Soleno Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Soleno Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.